Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma

Journal of Korean Medical Science

Volumn 29, Issue 1, 2014, Pages 48-52

  Lee, Jeonghun ^a   Song, Yeongpeck ^a   Soh, Euy Young ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Lymph node metastasis; Papillary thyroid carcinoma; Recurrence

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PAPILLARY CARCINOMA; PAPILLARY THYROID MICROCARCINOMA; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; THYROID CARCINOMA; THYROID TUMOR; THYROIDECTOMY; TUMOR RECURRENCE;

LYMPH NODE METASTASIS; PAPILLARY THYROID CARCINOMA; RECURRENCE;

CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84907424265     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2014.29.1.48     Document Type: Article

References (29)

1. Vasileiadis I, Karakostas E, Charitoudis G, Stavrianaki A, Kapetanakis S, Kouraklis G, Karatzas T. Papillary thyroid microcarcinoma: clinicopath-ological characteristics and implications for treatment in 276 patients. Eur J Clin Invest 2012; 42: 657-64.
2. Lee NS, Bae JS, Jeong SR, Jung CK, Lim DJ, Park WC, Kim JS, Kim SN. Risk factors of lymph node metastasis in papillary thyroid microcarcino-ma. J Korean Surg Soc 2010; 78: 82-6.
3. Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC. Clinical and histological character-istics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 2006; 91: 2171-8.
4. Cho BY. Clinical thyroidology. 3rd ed. Seoul: Korea Medical Book, 2010.
5. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Maz-zaferri EL, McIver B, Pacini F, Schlumberger M, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214.
6. Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel FK, et al. NCCN clinical practice guide-lines in oncology: thyroid carcinoma. Available at http://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf [accessed on 28 November 2013].
7. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goell-ner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998; 124: 958-64.
8. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the man-agement of patients with differentiated thyroid carcinoma of the follicu-lar epithelium. Eur J Endocrinol 2006; 154: 787-803.
9. Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X, Huang T. Multifocality and to-tal tumor diameter predict central neck lymph node metastases in papil-lary thyroid microcarcinoma. Ann Surg Oncol 2013; 20: 746-52.
10. Rodriguez JM, Moreno A, Parrilla P, Sola J, Soria T, Tebar FJ, Aranda F. Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 1997; 163: 255-9.
11. Kim WJ, Bae MJ, Yi YS, Jeon YK, Kim SS, Kim BH, Kim IJ. Clinicopatho-logic characteristics of papillary microcarcinoma in the elderly. J Korean Thyroid Assoc 2013; 6: 69-74.
12. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y. Lymph node metastasis from 259 papillary thy-roid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003; 237: 399-407.
13. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19: 545-76.
14. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treat-ment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 414-24.
15. Buffet C, Golmard JL, Hoang C, Trésallet C, Du Pasquier Fédiaevsky L, Fierrard H, Aurengo A, Menegaux F, Leenhardt L. Scoring system for predicting recurrences in patients with papillary thyroid microcarcino-ma. Eur J Endocrinol 2012; 167: 267-75
16. Shaha AR. Implications of prognostic factors and risk groups in the man-agement of differentiated thyroid cancer. Laryngoscope 2004; 114: 393-402.
17. Koo BS, Lim HS, Lim YC, Yoon YH, Kim YM, Park YH, Rha KS. Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma. Ann Surg Oncol 2010; 17: 1101-5.
18. Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP. Prophylactic lymph node dissec-tion for papillary thyroid cancer less than 2 cm: implications for radioio-dine treatment. J Clin Endocrinol Metab 2009; 94: 1162-7.
19. Rose RG, Kelsey MP, Russell WO, Ibanez ML, White EC, Clark RL. Fol-low-up study of thyroid cancer treated by unilateral lobectomy. Am J Surg 1963; 106: 494-500.
20. Pasieka JL, Thompson NW, McLeod MK, Burney RE, Macha M. The in-cidence of bilateral well-differentiated thyroid cancer found at comple-tion thyroidectomy. World J Surg 1992; 16: 711-6.
21. Borson-Chazot F, Causeret S, Lifante JC, Augros M, Berger N, Peix JL. Predictive factors for recurrence from a series of 74 children and adoles-cents with differentiated thyroid cancer. World J Surg 2004; 28: 1088-92.
22. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Maz-zaferri EL, Mclver B, Sherman SI, Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thy-roid 2006; 16: 109-42.
23. Choi JS, Kim J, Kwak JY, Kim MJ, Chang HS, Kim EK. Preoperative stag-ing of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am J Roentgenol 2009; 193: 871-8.
24. Shimamoto K, Satake H, Sawaki A, Ishigaki T, Funahashi H, Imai T. Pre-operative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998; 29: 4-10.
25. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Rou-tine ipsilateral level VI lymphadenectomy reduces postoperative thyro-globulin levels in papillary thyroid cancer. Surgery 2006; 140: 1000-5.
26. Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 1214-6.
27. Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau JL, Racadot A, Proye C. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg 1998; 22: 718-24.
28. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, Hor-ster FA, Röher HD. Surgical reintervention for differentiated thyroid can-cer. Br J Surg 1993; 80: 1009-12.
29. Caliskan M, Park JH, Jeong JS, Lee CR, Park SK, Kang SW, Jeong JJ, Chung WY, Park CS. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma. Endocr J 2012; 59: 305-11.